Plato Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.49M Buy
74,299
+9,877
+15% +$1.16M 0.54% 37
2026
Q1
$7.75M Sell
64,422
-3,107
-5% -$359K 0.52% 37
2025
Q4
$7.14M Sell
67,529
-525
-0.8% -$49.3K 0.47% 41
2025
Q3
$5.67M Buy
68,054
+4,927
+8% +$406K 0.38% 52
2025
Q2
$4.98M Buy
63,127
+4,035
+7% +$321K 0.37% 59
2025
Q1
$5.36M Buy
59,092
+8,468
+17% +$791K 0.45% 40
2024
Q4
$5.05M Hold
50,624
0.37% 59
2024
Q3
$5.74M Buy
50,624
+457
+0.9% +$54.3K 0.47% 41
2024
Q2
$6.21M Buy
50,167
+2,811
+6% +$362K 0.58% 31
2024
Q1
$6.25M Buy
47,356
+40,734
+615% +$5.02M 0.65% 26
2023
Q4
$722K Buy
+6,622
New +$687K 0.89% 21

Other funds holding MRK

Plato Investment Management's MRK Position: Q2 2026 in Review

Plato Investment Management increased its Merck (MRK) stake by 15% in Q2 2026, buying an estimated $1.16M and bringing the position to 74,299 shares worth $9.49M. The position accounts for 0.54% of the portfolio, ranked #37.

Plato Investment Management first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. 3,843 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Plato Investment Management held 74,299 shares of Merck worth $9.49M as of Q2 2026.
  • Plato Investment Management bought 9,877 Merck shares in Q2 2026, an estimated $1.16M.
  • Merck made up 0.54% of Plato Investment Management's portfolio in Q2 2026, its #37 holding.
  • Plato Investment Management first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • 3,843 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.